Track topics on Twitter Track topics that are important to you
Axonyx is a biopharmaceutical company focused on the acquisition and development of proprietary products and technologies for the treatment and diagnosis of Alzheimer's Disease and other memory-related cognitive disorders including prion diseases such as Mad Cow Disease. After completion of a Phase II Proof of Concept clinical study in October of 2001 for Phenserine, Axonyx's lead product for Alzheimer's Disease, Axonyx is undertaking preparations for Phase III clinical trials for Phenserine. Axonyx's other drug candidates are in preclinical development.
825 Third Avenue, 40th Floor
United States of America
Phone: 212 688 4770
Fax: 212 688 4843
Axonyx is a biopharmaceutical company focused on the acquisition and development of proprietary products and technologies for the treatment and diagnosis of Alzheimer's Disease and other memory-relate...
Axonyx' mission is to be the leading biopharmaceutical company that develops products and technologies to treat Alzheimer's disease (AD) and other Central Nervous System (CNS) disorders. Axonyx' busin...
AXYX is engaged in the business of identifying and acquiring novel post-discovery central nervous system (CNS) drug candidates to advance through clinical development towards regulatory approval an...
We have published hundreds of Axonyx news stories on BioPortfolio along with dozens of Axonyx Clinical Trials and PubMed Articles about Axonyx for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axonyx Companies in our database. You can also find out about relevant Axonyx Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...